Annual Total Liabilities
$38.58 M
+$1.31 M+3.51%
December 31, 2023
Summary
- As of February 26, 2025, PLRX annual total liabilities is $38.58 million, with the most recent change of +$1.31 million (+3.51%) on December 31, 2023.
- During the last 3 years, PLRX annual total liabilities has risen by +$26.11 million (+209.49%).
- PLRX annual total liabilities is now -67.72% below its all-time high of $119.50 million, reached on December 31, 2019.
Performance
PLRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$99.84 M
+$8.79 M+9.65%
September 30, 2024
Summary
- As of February 26, 2025, PLRX quarterly total liabilities is $99.84 million, with the most recent change of +$8.79 million (+9.65%) on September 30, 2024.
- Over the past year, PLRX quarterly total liabilities has stayed the same.
- PLRX quarterly total liabilities is now -16.45% below its all-time high of $119.50 million, reached on December 31, 2019.
Performance
PLRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PLRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.5% | 0.0% |
| 3 y3 years | +209.5% | 0.0% |
| 5 y5 years | -42.8% | 0.0% |
PLRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.1% | at high | +350.6% |
| 5 y | 5-year | -67.7% | +209.5% | -16.4% | +851.3% |
| alltime | all time | -67.7% | +209.5% | -16.4% | +851.3% |
Pliant Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $99.84 M(+9.7%) |
| Jun 2024 | - | $91.05 M(+8.0%) |
| Mar 2024 | - | $84.27 M(+118.4%) |
| Dec 2023 | $38.58 M(+3.5%) | $38.58 M(+3.1%) |
| Sep 2023 | - | $37.42 M(-10.5%) |
| Jun 2023 | - | $41.83 M(+16.3%) |
| Mar 2023 | - | $35.96 M(-3.5%) |
| Dec 2022 | $37.27 M(+68.2%) | $37.27 M(-7.3%) |
| Sep 2022 | - | $40.19 M(+9.1%) |
| Jun 2022 | - | $36.83 M(+58.6%) |
| Mar 2022 | - | $23.23 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $22.16 M(+77.7%) | $22.16 M(+61.9%) |
| Sep 2021 | - | $13.68 M(+16.6%) |
| Jun 2021 | - | $11.74 M(+5.9%) |
| Mar 2021 | - | $11.09 M(-11.1%) |
| Dec 2020 | $12.46 M(-89.6%) | $12.46 M(+4.1%) |
| Sep 2020 | - | $11.98 M(-7.8%) |
| Jun 2020 | - | $12.99 M(+23.7%) |
| Mar 2020 | - | $10.49 M(-91.2%) |
| Dec 2019 | $119.50 M(+77.3%) | $119.50 M(+490.1%) |
| Jun 2019 | - | $20.25 M(+19.3%) |
| Dec 2018 | $67.41 M | - |
| Dec 2018 | - | $16.97 M |
FAQ
- What is Pliant Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Pliant Therapeutics?
- What is Pliant Therapeutics annual total liabilities year-on-year change?
- What is Pliant Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly total liabilities year-on-year change?
What is Pliant Therapeutics annual total liabilities?
The current annual total liabilities of PLRX is $38.58 M
What is the all time high annual total liabilities for Pliant Therapeutics?
Pliant Therapeutics all-time high annual total liabilities is $119.50 M
What is Pliant Therapeutics annual total liabilities year-on-year change?
Over the past year, PLRX annual total liabilities has changed by +$1.31 M (+3.51%)
What is Pliant Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PLRX is $99.84 M
What is the all time high quarterly total liabilities for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly total liabilities is $119.50 M
What is Pliant Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PLRX quarterly total liabilities has changed by $0.00 (0.00%)